Combined hormonal contraceptives: higher VTE risk

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2014年 / 1517卷 / 1期
关键词：
D O I：
10.1007/s40278-014-3073-x
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 9
相关论文
共 50 条
  • [21] Impact of combined hormonal contraceptives on vessels functionality
    Alessandro Rabiolo
    Federico Corvi
    Davide Monteduro
    Lucia Benatti
    Maria Vittoria Cicinelli
    Giovanni Fogliato
    Giuseppe Querques
    Francesco Bandello
    Archives of Gynecology and Obstetrics, 2016, 294 : 1317 - 1322
  • [22] Impact of combined hormonal contraceptives on vessels functionality
    Rabiolo, Alessandro
    Corvi, Federico
    Monteduro, Davide
    Benatti, Lucia
    Cicinelli, Maria Vittoria
    Fogliato, Giovanni
    Querques, Giuseppe
    Bandello, Francesco
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 294 (06) : 1317 - 1322
  • [23] Combined hormonal contraceptives and migraine: An update on the evidence
    Calhoun, Anne H.
    Batur, Pelin
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2017, 84 (08) : 631 - 638
  • [24] Study links oral and nonoral hormonal contraceptives with higher risk of female sexual dysfunction
    不详
    WOMENS HEALTH, 2010, 6 (04) : 492 - 492
  • [25] Hormonal contraceptives and cancer risk Response
    Singh, Kamalinder K.
    CONTRACEPTION, 2012, 86 (06) : 772 - 772
  • [26] Cardiovascular risk of hormonal contraceptives - an update
    Dinger, J.
    GYNAKOLOGE, 2015, 48 (09): : 643 - 650
  • [27] Hormonal Contraceptives and the Risk of Venous Thrombosis
    Khialani, Deeksha
    Rosendaal, Frits
    Vlieg, Astrid van Hylckama
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2020, 46 (08): : 865 - 871
  • [28] Hormonal contraceptives and the risk of gestational diabetes
    Reactions Weekly, 2006, 1108 (1) : 1 - 1
  • [29] No increased VTE risk with anticoagulants ± hormonal therapy
    Reactions Weekly, 2016, 1584 (1) : 9 - 9
  • [30] VTE Risk in Users of Combined Oral Contraceptives: Impact of a 24-Day Regimen Containing Drospirenone
    Reed, Suzanne
    Bardenheuer, Kristina
    Dinger, Juergen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 169 - 170
12345